dcc-3009
·Code: DCC-3009
dcc-3009: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Deciphera Pharmaceuticals, Inc. (DCPH) | Phase 1/Phase 2 |
Clinical Trials (1)
A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)
Frequently asked questions
Who is developing dcc-3009?
dcc-3009 is being developed by Deciphera Pharmaceuticals, Inc..
How many clinical trials involve dcc-3009?
BioSniper tracks 1 clinical trial involving dcc-3009.
Get deeper analysis on dcc-3009
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis